Predictive MRI biomarkers in MS—A critical review
Background and Objectives: In this critical review, we explore the potential use of MRI
measurements as prognostic biomarkers in multiple sclerosis (MS) patients, for both …
measurements as prognostic biomarkers in multiple sclerosis (MS) patients, for both …
Predicting long-term disability in multiple sclerosis: a narrative review of current evidence and future directions
B Weinstock-Guttman, MP Sormani… - … Journal of MS Care, 2022 - meridian.allenpress.com
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is
integral to patient care. The Expanded Disability Status Scale (EDSS) is a commonly used …
integral to patient care. The Expanded Disability Status Scale (EDSS) is a commonly used …
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France
J Ciron, B Bourre, G Castelnovo, AM Guennoc… - Neurology and …, 2024 - Springer
Cladribine tablets (CladT) has been available for therapeutic use in France since March
2021 for the management of highly active relapsing multiple sclerosis (RMS). This high …
2021 for the management of highly active relapsing multiple sclerosis (RMS). This high …
[HTML][HTML] Monitoring response to disease-modifying treatment in multiple sclerosis
J Río, J Peña, L Brieva, JM García-Domínguez… - Neurology …, 2023 - Elsevier
Background Standard criteria for defining suboptimal response to disease-modifying
treatment (DMT) in patients with multiple sclerosis (MS) are lacking. Decision-making on …
treatment (DMT) in patients with multiple sclerosis (MS) are lacking. Decision-making on …
[HTML][HTML] Evaluation of the expressed miR-129 and miR-549a in patients with multiple sclerosis
M Montazeri, N Eskandari… - Advanced Biomedical …, 2021 - journals.lww.com
Background: The expression of microRNAs (miRNAs) as circulating biomarkers has been
underlined in multiple sclerosis (MS) in the last decade. Due to the presence of a possible …
underlined in multiple sclerosis (MS) in the last decade. Due to the presence of a possible …
[PDF][PDF] RESCHWEIN Cécile Emmanuelle
ADELAP DES RELAIS - 1994 - publication-theses.unistra.fr
Depuis les années 1990, la prise en charge de la sclérose en plaques (SEP),
principalement de la forme récurrente-rémittente, s' est vue modifiée du fait du …
principalement de la forme récurrente-rémittente, s' est vue modifiée du fait du …
[引用][C] Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France
JCBBG Castelnovo, CSP Vermersch - 2024